HUGE News and Press, FSD Pharma Inc. From 06/03/20

Delta, Kelowna, BC - June 3, 2020 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca release today's podcast edition of cannabis news and stocks to watch plus insight from t...

FSD Pharma (NASDAQ: HUGE ) is up  116%  premarket on the heels of  announcement that the FDA has permitted company to submit an Investigational New Drug (IND) Application for the use of FSD-201 (ultramicronized palmitoylethanolamide, or ultramicronized PEA) to treat COVI...

FSD Pharma Receives U.S. FDA Approval to design a Phase 2a Clinical Trial to Treat Patients with Suspected or Confirmed COVID-19 Diagnosis Canada NewsWire TORONTO, June 3, 2020 TORONTO , June 3, 2020 /CNW/ -  FSD Pharma Inc. (Nasdaq: HUGE) (CSE: HUGE.CN) (FRA: ...

FSD Pharma Inc. (Nasdaq: HUGE) (CSE: HUGE.CN) (FRA: 0K9A) (“FSD Pharma” or the "Company") today announced that the U.S. Food and Drug Administration (FDA) has given the company permission to submit an Investigational New Drug Application (IND) for the use of FSD-201 (ultramicr...

FSD Pharma (NASDAQ: HUGE ) has announced the sale of 5M common shares of Pharmadrug Inc. (formerly Aura Health) in a privately negotiated transaction at C$0.08/share for cash proceeds of C$400,000. More news on: FSD Pharma Inc., Read more ...

- Buyer Holds Option to Purchase Additional Shares - FSD Pharma Inc. (NASDAQ:HUGE) (CSE:HUGE.CN) (FRA:0K9A) (“FSD Pharma” or the "Company") today announced the sale of 5.0 million common shares of Pharmadrug Inc. (CSE:BUZZ) (formerly Aura Health) in a privately negotiat...

Provides Business Update FSD Pharma Inc. (Nasdaq: HUGE) (CSE: HUGE.CN) (FRA: 0K9A) (“FSD Pharma” or the “Company”) today reported that management’s discussion and analysis of financial condition and results of operations (“MD&A”)...

FSD Pharma Inc. (Nasdaq: HUGE) (CSE: HUGE.CN) (FRA: 0K9A) (“FSD Pharma” or the "Company") today announced that it has taken steps to mitigate the impact of the novel coronavirus SARS-CoV-2 pandemic on its wholly-owned subsidiary, FV Pharma Inc. (“FV Pharma”), a l...

Vancouver, British Columbia--(Newsfile Corp. - March 10, 2020) - FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FSE: 0K9), a specialty, biotech pharmaceutical R&D company focused on developing, over time, a robust pipeline of FDA approved synthetic compounds targeting the endocannabinoid syst...

FSD Pharma Inc. (Nasdaq: HUGE) (CSE: HUGE) (FRA: 0K9A) (“FSD Pharma” or the "Company") today announced receipt of approval from the Ethics Committee of the Alfred Hospital, part of the Alfred Health group of hospitals serving the state of Victoria in Australia, to initiate a P...